The early hours of Saturday through Sunday Quebec Videoton Center (Canada) will hang a no ticket sign to see one of the great fights this 2024, will face Russian nationalized Canadian Artur Beterviev (19-0-0, 19 KOs) and in british Callum Smith (29-1-0, 21 KOs).
Beterviev – a boxer with real marble in his hands, with 100% effectiveness in his victories – putting his WBC, WBO and IBF light heavyweight belts on the line. So far everything is normal, but due to the possibility of Beterviev entering the ring, some questions have arisen as to why he is allowed to do so if in some controls to which he has undergone his results have revealed ‘atypical findings’ ‘.
To make things clear World Boxing Council (WBC) has released a statement explaining everything. “Two samples (one urine and one blood) collected on December 6, 2023 returned analytical ‘atypical findings’ for 5b-androstanediol and hGH (human growth hormones). An atypical finding is not a positive results for a prohibited substance World Anti-Doping Agency (WADA) defines an atypical finding as “a report from a laboratory or other WADA-approved entity that requires further investigation.” It was conducted by Voluntary Anti-Doping Association (VADA)when he ruled WBC Clean Boxing Program.
Point to the World Boxing Council that “VADA immediately ordered additional doping tests on champion Beterbiev. It requested to take new samples from champion Beterbiev on December 15, 2023 (urine), December 21, 2023 (blood and urine) and then again on December 3 January 2024 (blood ) All these samples returned absolutely negative results. Matchroom, Top Rank, the Quebec Commissionall sanctioning bodies involved (WBC, IBF and WBO) and the Association of Boxing Commissions (ABC) received notifications of all the results of the anti-doping tests carried out by the champion Beterbiev and, therefore, of all the follow-up procedures.”
And the WBC clarified that “there is no way to determine the source of an atypical finding. In the case of 5b-androstanediol, it has been reported that the atypical finding may be due to the speed with which some people’s bodies metabolize natural testosterone-like compound. In the case of hGH, WADA provides specific criteria to its accredited laboratories for reporting hGH levels as atypical or adverse findings. In the case of champion Beterbiev , the hGH level detected does not meet the WADA criteria for an adverse finding and therefore constitutes an atypical finding.
Since the origin of an atypical finding is very difficult to determine, the LOVE It is recommended to always perform more tests to monitor any abnormal variations in testosterone levels. In the case of champion Beterbiev, “follow-up tests were not only negative, but showed a constant testosterone level without any spikes that might suggest exogenous ingestion of performance-enhancing substances. In summary, the test protocol of the champion “Beterbiev and his results lead to only one conclusion: no bad results. In light of the measurements of the tests carried out and all the results obtained, the WBC has not taken and will not take any adverse action in this matter,” concluded World Boxing Council.
Source: La Verdad
I’m Robert Maynard, and I am a passionate journalist with experience in sports writing. For the last few years, I have been writing for Today Times Live. My main focus has been on sports-related stories and features. With my strong background in journalism and extensive knowledge of the industry, I am able to provide readers with well-crafted pieces that are both informative and engaging.
